journal1 ›› 2018, Vol. 26 ›› Issue (10): 1104-1106.DOI: 10.11852/zgetbjzz2018-26-10-16

Previous Articles     Next Articles

Research progress on methylphenidate in the treatment of attention deficit hyperactivity disorder

HU Chun-shui1, JIANG Wen-qing2, SHEN Hong-yan1, DU Ya-song2   

  1. 1 Jiading Mental Health Center,Shanghai 201806,China;
    2 Shanghai Mental Health Center,Shanghai Jiao Tong University School of Medicine,Shanghai 200030,China
  • Received:2017-11-10 Online:2018-10-10 Published:2018-10-10
  • Contact: DU Ya-song,E-mail:yasongdu@163.com

哌甲酯治疗注意缺陷多动障碍的研究进展

胡春水1, 江文庆2, 沈红艳1, 杜亚松2   

  1. 1 上海市嘉定区精神卫生中心,上海 201806;
    2 上海交通大学医学院附属精神卫生中心,上海 200030
  • 通讯作者: 杜亚松,E-mail:yasongdu@163.com
  • 作者简介:胡春水(1987-),男,主治医师,主要研究方向为儿童青少年精神疾病的诊治。

Abstract: Methylphenidate is a representative drug for attention deficit hyperactivity disorder (ADHD).It helps to control symptoms and to improve social function.More children with ADHD should have benefit from methylphenidate treatment.But patients can not get proper treatment because of their fear of side effects.This review will focus on the efficacy and side effect of methylphenidate,and make comparison between methylphenidate and atomoxetine.

Key words: methylphenidate, attention deficit hyperactivity disorder, adverse drug reaction, therapy

摘要: 哌甲酯是治疗注意缺陷多动障碍(ADHD)的一线药物,能够改善ADHD临床症状和社会功能。本应有更多的ADHD儿童从哌甲酯治疗中获益,但是由于对哌甲酯不良反应过度担心,患儿得不到合适的治疗,造成疾病负担加重。本文主要从哌甲酯治疗ADHD的疗效、不良反应、与托莫西汀的比较等几个方面,对哌甲酯治疗ADHD做一综述。

关键词: 哌甲酯, 注意缺陷多动障碍, 不良反应, 治疗

CLC Number: